Biosecurity Modernization and Innovation Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Biosecurity Modernization and Innovation Act of 2026, changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Science & Space, Healthcare.
Who Benefits and How
federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Biosecurity Modernization and Innovation Act of 2026.
- Section id04f996003d544f22b19fd49159ea268d: 2. Definitions In this Act: The term covered provider means a person who— synthesizes and sells synthetic nucleic acids to persons in the United States; or...
- Section idaaa54ea9155341c3a005be75ff1c89e7: 3. Sense of Congress It is the Sense of Congress that— the field of biotechnology is accelerating and the United States is at risk of losing its biotechnology...
- Section idaafb91bab87d4d918e7ecb2b00016d70: 4. Nucleic acid synthesis security Not later than 1 year after the date of the enactment of this Act, the Secretary shall, in coordination with the Under...
- Section ida40ec5251c9144f885428a5135cd49e0: 5. Establishment of biotechnology governance sandbox Not later than 1 year after the date of the enactment of this Act, the Under Secretary shall, in...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Biosecurity Modernization and Innovation Act of 2026, changes federal law or congressional policy affecting federal agencies and legislative administrators.
Key Policy Areas
Government Operations, Science & Space, Healthcare
Primary Purpose
This bill, Biosecurity Modernization and Innovation Act of 2026, changes federal law or congressional policy affecting federal agencies and legislative administrators.
Policy Domains
Whole bill
Identified Gains
- federal agencies and legislative administrators
Identified Costs
- federal implementing agencies
Sponsors
Legislative Progress
In CommitteeRead twice and referred to the Committee on Commerce, Science, …
Introduced in Senate
Mr. Cotton (for himself and Ms. Klobuchar) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_commerce"
- → Secretary of Commerce
Key Definitions
Terms defined in this bill
a person who— synthesizes and sells synthetic nucleic acids to persons in the United States
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology